The Discovery Europe 2023 Conference brings together leading experts in the fields of Organoid Discovery, Phenotypic Screening, Targeted Protein Degradation, AI Computational Drug Design and Lead Optimization. Join and network with over 400 industry leaders at the renowned Drug Discovery Summit in Berlin, where we will address the latest advancements in target identification, validation and HIT optimization. Exploring the latest advancements in phenotypic and target-based discovery, chemical biology as well as drug design at our two-day summit. The event will bring together leading experts in the fields of Organoid Discovery, Phenotypic Screening, Targeted Protein Degradation, AI Computational Drug Design and Lead Optimization. The 2023 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook. Below were some of the key speakers from our Discovery Europe 2022 event. Malcolm Weir, Executive Officer, Vice President at Sosei Heptares Ulrich Betz, Vice President Innovation, Head of Department Innovation Incubator at Merck Matthias Frech, Director, Molecular Interactions & Biophysics at Merck Clara Christ, Head of Computational Molecular Design at Bayer Olivier Nosjean, Head of Open Innovation and Scientific Affairs, R&D at Servier Nadeem Sarwar, Global Head, Genomic Strategies & Global Head, Digital Therapeutics (DTx) Strategies at Eisai.
Read on oxfordglobal.co.uk

Continue reading at oxfordglobal.co.uk

Drug Discovery Artificial Intelligence

Facebook Share

Twitter Share

Linkedin Share

Email Share